A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, multicenter trial with a 4-way
crossover design. Elderly subjects with primary insomnia who meet screening requirements will
initially be randomized into the study and receive the first of 4 treatments (PD 0200390 5
mg, 15 mg and 30 mg or placebo) daily 30 minutes before bed time for 2 consecutive days in a
polysomnography (PSG) lab.